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A continuous peripheral nerve block (cPNB) is provided in the hospital and ambulatory setting. The most common use of CPNBs
is in the peri- and postoperative period but diﬀerent indications have been described like the treatment of chronic pain such
as cancer-induced pain, complex regional pain syndrome or phantom limb pain. The documented beneﬁts strongly depend
on the analgesia quality and include decreasing baseline/dynamic pain, reducing additional analgesic requirements, decrease of
postoperative joint inﬂammation and inﬂammatory markers, sleep disturbances and opioid-related side eﬀects, increase of patient
satisfactionandambulation/functioningimprovement,anacceleratedresumptionofpassivejointrange-of-motion,reducingtime
until discharge readiness, decrease in blood loss/blood transfusions, potential reduction of the incidence of postsurgical chronic
pain and reduction of costs. Evidence deriving from randomized controlled trials suggests that in some situations there are also
prolonged beneﬁts of regional anesthesia after catheter removal in addition to the immediate postoperative eﬀects. Unfortunately,
there are only few data demonstrating beneﬁts after catheter removal and the evidence of medium- or long-term improvements
in health-related quality of life measures is still lacking. This review will give an overview of the advantages and adverse eﬀects of
cPNBs.
1.Background
Since its ﬁrst description in 1946, cPNB has evolved from
ac a s er e p o r to fan e e d l ei n s e r t e dt h r o u g hac o r kt a p e dt o
a patient’s chest to a wide-spread and validated analgesic
technique in the postoperative setting [1]. The earliest
reports of cPNB focused on prolonging intraoperative surgi-
cal anesthesia and the treatment of intractable hiccups [1–3].
The indication for cPNB has evolved since then, and many
indications have been described in the literature: treatment
of vasospasm induced by Raynaud disease [4]; induction
of sympathectomy and vasodilation for improvement of
blood ﬂow after vascular surgery/trauma [5, 6], replantation
or limb salvage [7, 8]; treatment of peripheral embolism
[9, 10]; analgesia in the setting of trauma [11]; treatment
of chronic pain syndrome such as trigeminal neuralgia [12],
complex regional pain syndrome [13], terminal cancer pain,
[14], and phantom limb pain [15, 16]. Independently of
these indications, the majority of publications dealing with
cPNB focus on postsurgical pain treatment, where evidence
supports the concept that regional anesthesia and analgesia
oﬀers superior pain relief to systemic opioid analgesia
following major surgery [17]. However, postsurgical pain
is the only indication which has been validated using
randomized controlled trials (RCTs) [18–22]. Compared
with opioid analgesics cPNBs provide superior analgesia
with a lower incidence of opioid-induced side eﬀects like
nausea, vomiting, pruritus, and sedation [21]. Moreover,
in a meta-analysis Rodgers et al. suggested that mortality
associated with major surgery was reduced by 30% when
central regional anesthesia was used combined or not with
general anesthesia [23]. On the other hand, a Cochrane
review showed no impact of regional anesthesia compared
to general anesthesia on mortality after hip fracture. Only
the acute postoperative confusion was reduced after regional
anesthesia [24]. However, for continuous peripheral regional
anesthesia these ﬁndings cannot be extrapolated. Though,
continuous peripheral regional anesthesia oﬀers improved
functional outcomes after extremity surgery at least for a
short term period (up to 6 months) [25–27].
Despite this evidence of value, the hypothesis that
regional anesthesia has an overall beneﬁcial and long-lasting2 Anesthesiology Research and Practice
Table 1: Incidence of persistent postsurgical pain and associated
disability. Based on data from [37, 71–73].
Surgery Incidence Severe disability
Amputation 30–85% 5–10%
Thoracotomy 5–67% 10%
Inguinal hernia repair 10–30% 2–4%
Breast surgery 11–65% 5–10%
Coronary artery bypass graft 30–50% 5–10%
Cesarean section 10–18% 4%
eﬀect on patient outcome following surgery still remains
diﬃcult to prove and has been challenged, especially in times
with reduced resources. For more than 30 years, regional
anesthesia has challenged anesthesiologists to determine
whether it oﬀers real beneﬁts over other types of anesthesia,
such as preserving cognitive function after major surgery
compared to general anesthesia, improving long-term joint
function and rehabilitation leading to earlier return to work,
reducing costs, reducing the need for blood transfusions and
increasing patient-reported outcomes such as satisfaction,
quality of life, and quality of recovery.
The implications of regional anesthesia after major sur-
gery are multifaceted and not fully elucidated, thus requiring
future studies with a focus on evaluating issues like implicat-
ing roles of mismanaged pain, environmental factors, stress
responses associated with the perioperative period, long-
term followups focusing on joint mobilisation and quality of
life.
This paper will elucidate the beneﬁts of cPNB over intra-
venous analgesia and single-shot perineural blocks (sPNB)
according to the published literature and show some aspects
for possible future directions.
2. The Need for Optimal PostsurgicalAnalgesia
In western countries, 50–70% of in hospital patients suﬀer
from moderate-to-severe pain after surgery [28], and 40%
of ambulatory surgical patients have moderate/severe pain
duringtheﬁrst24–48h[29].Orthopedicsurgeryremainsthe
major indication for peripheral nerve blocks for anesthesia
and postoperative analgesia [30]. Orthopedic surgery is one
of the most if not the most painful surgery [31, 32]. In
fact, after orthopedic surgery signiﬁcant increases in pain
scores may persist for 2 to 3 days [33, 34]. In postoperative
evaluations of hip and knee surgeries using questionnaires
28% of patients after total hip arthroplasty [35] and 33%
of patients after total knee arthroplasty [36]s u ﬀered from
chronic pain. The common ﬁnding between these patients
was the intensity of immediate postoperative pain. Intense
persistent postsurgical pain has indeed been described as a
risk factor for the development of chronic pain [37, 38].
Therefore, an improvement in postsurgical pain therapy
could be an important factor to reduce pain chroniﬁcation
and its adverse eﬀects on health system costs [39]( Table 1).
Figure 1: Sterile precautions for regional anesthesia.
3. cPNB InsertionTechniques
3.1. Skin Preparation and Patient Draping. Sterility is of
utmost importance for the performance of cPNB indepen-
dently of the technique performed (neurostimulation or
ultrasound). The American Society of Regional Anesthesia
and Pain Medicine (ASRA) recommends antiseptic hand
washing, sterile gloves, surgical mask and hats, and the
use of alcohol-based chlorhexidine antiseptic solutions [40].
Further sterile protection of the ultrasound probe is essential
[41]. The catheter dressing after insertion has to be sterile
and transparent to avoid and recognize catheter infection
(Figures 1 and 2).
3.2. Needle Choice. Short bevel needles are widely accepted
as standard practice in regional anesthesia. The literature is
not conclusive to support the notion that nerve injury is
minimized using short bevel needles [42–44]. The use of
ultrasound for catheter placement is increasing and apart
from thin-walled needles also Tuohy needles remain popular
with this technique. However, despite the use of ultrasound,
the risk of intraepineurial local anesthetic injections may be
quitecommonasdescribedbyLiuetal.inalargeprospective
study on ultrasound-guided interscalene and supraclavicular
blockade for shoulder surgery [45] and diﬀerent case reports
[46, 47]. For fascia iliaca blocks a blunt needle (pencil point
or Tuohy) oﬀers a better recognition of a “pop” as tactile
feedback when the diﬀerent fascias are pierced [48].
3.3. Nerve Stimulation. Before introduction of portable
nerve stimulators in 1962 [49], PNB were performed using
induced paresthesia (“no paresthesia and no analgesia”),
[50] fascial “pop,” [51] or even with ﬂuoroscopic guidance
[52]. Despite the fact that there has never been a repeated
comparison of nerve stimulation and paresthesia which hasAnesthesiology Research and Practice 3
Figure 2: Sterile catheter dressing after catheter tunneling.
been for a long time the most wide-spread technique and
is still used, nerve stimulation has been considered the gold
standard at least until the introduction of ultrasound in 1989
[53]. Using electrical current to place an insulated needle
close to a peripheral nerve to inject local anesthetic or place a
perineural catheter is the basic principle of nerve stimulation
[54]. Without doubt, if properly used nerve stimulation
oﬀersahighsuccessrateforsPNBandforcPNB[55–62].The
most important rules to achieve competitive success rates for
sPNB are
(i) use a proper technique with logical (adaptable to all
patients,independentofbodyheightandweight)and
reproducible landmarks [56–59];
(ii) accept only responses with previously described high
success rate (e.g., distal responses of the posterior
cord for infraclavicular block; inversion for popliteal
block) [56, 57, 63];
(iii) injectonlyatfollowingnervestimulator setting (with
still weak motor response visible): amplitude width:
0.1ms, frequency: 2Hz, and impulse: 0.3–0.4mA;
(iv) use the correct block for the planned surgery (e.g.,
not an interscalene block for elbow surgery [64]b u t
an infraclavicular block) (Table 2).
Oftencomparativestudieswhichdescribedunacceptablelow
success rate for nerve stimulation are based on violation
of at least one of the above-mentioned principles [64–67].
Although unclear data exists showing a consistent relation-
ship between stimulating current and proximity to the nerve
[68–70], the above-mentioned nerve stimulator setting is
associatedwithhighsuccessandlowcomplicationrates[56].
For catheter placement, it is of prime importance that
the needle is guided tangentially to the nerve to avoid nerve
injury and to guarantee a catheter placement parallel to
the nerve (Figure 3). In this case, a 3-oriﬁce catheter will
facilitateaspreadofthelocalanestheticalongthenervecom-
pared with an end-oriﬁce catheter. To avoid early catheter
displacement, the insertion should be performed before
injection of local anesthetic [74]. To our mind, for catheter
placement the cannula over the needle technique [26]
threading the perineural catheter 3-4cm past the tip of
Figure 3: Cannula over the needle technique.
the cannula with subsequent subcutaneous tunneling for 4-
5cm to avoid displacement after insertion is the technique
of choice (Figures 3, 4, 5 and 6). The optimal distance to
advance a perineural catheter past the needle tip remains
unknown according to the literature, but data suggests that
increasing the insertion distance >5cm is correlated with an
increased risk of catheter coiling [75]. As there is no data
suggesting insertion lengths >5cm, the maximal insertion
depth should be considered 5cm [75, 76].
An further option is the use of stimulating catheters:
with an insulated needle electrical current is used to locate
the target nerve, followed by the insertion of a perineural
catheter that conducts current to its tip [77]. Although there
is evidence supporting some advantages in certain anatomic
locations (popliteal fossa, femoral, and interscalene region)
[78–80], the clinical relevance considering the signiﬁcantly
increased material costs remains unclear [81–83].
3.4. Ultrasound. The introduction of ultrasound for regional
anesthesia has been an important development. First it was
considered a supplement to nerve stimulation, now it is
recognized as a “stand-alone” technique [84]. Unfortunately,
a nonending dispute between nerve stimulation and ultra-
sound has distracted the focus of interest from clinically
important questions [85, 86]. Almost all comparative studies
violate in a way or another at least one of the crucial
points for correct nerve stimulation mentioned above and
have been subject to criticism [87–89]. The recent review
by Abrahams et al. [90] dealing with this topic emphasized
the superiority of ultrasound according to the present
“evidence” and was severely disputed in web publications
of letters to the editor [91]. There are also some publica-
tionscomparingultrasound-guidedcatheterinsertionversus
nerve stimulation catheter insertion [92–95]. Actually, some
of these studies report at least similar analgesia between4 Anesthesiology Research and Practice
Figure 4: Catheter insertion through the cannula. Catheter is
advanced up to 5cm over the cannula tip.
Figure 5: Cannula removal leaving the catheter in place.
both techniques [96–98]. Regrettably, in most of these
publications the inappropriate use of neurostimulation lead
to intolerable low success rates (<80%). Moreover, surrogate
outcome like needle passes through the skin, needle time
under the skin, patient satisfaction, local anesthetic vol-
ume, and other parameters of doubtful clinical importance
have been introduced to compare these techniques. The
comparison of ultrasound with stimulating catheters shows
a similar picture: ultrasound is at least as eﬀective with
improvement of insertion-related discomfort and insertion
time [93, 99]. The limited length and the main focus of this
Figure 6: Catheter tunneling.
Table 2: Suggested catheter insertions for diﬀerent surgical pro-
cedures. First choice is the ﬁrst mentioned. The used literature
for interscalene [58, 103, 104], cervical paravertebral [105–109],
infraclavicular [59, 110–113], supraclavicular [114–116], axillary
block [117–119], psoas compartment [120, 121], fascia iliaca [122–
124], femoral [125–127], obturator [128, 129], popliteal sciatic
[56, 57] ,a n dp r o x i m a ls c i a t i c[ 130–133].
Surgery Catheter insertion location
Shoulder/proximal
humerus Interscalene; cervical paravertebral
Distal humerus, elbow,
forearm, and hand
Infraclavicular; supraclavicular; axillary
block
Hip Psoas compartment; fascia iliaca; femo-
ral
Thigh/knee Femoral; fascia iliaca; obturator; proxi-
mal sciatic
Calf/ankle/foot
Sciatic (popliteal; proximal); add femo-
ral nerve block for major ankle surgery
[26]
review preclude a further indepth discussion of this topic.
Indeed, there are randomized controlled trials suggesting
that stimulating catheters for popliteal blocks [100], and
the combination of ultrasound and nerve stimulation for
catheter insertion improve analgesia [101]. Both techniques
have to be considered equal if properly used with the
respective advantages and disadvantages. This statement is
in accordance with the most recent recommendation of the
ASRA [102].
Data from controlled trials involving ultrasound-guided
sPNB is not automatically applicable to ultrasound-guided
cPNB. However, many reports conﬁrm the feasibility of
ultrasound-guided catheter-insertion with a great success
rate [134, 135] also if there are few RCTs available [19,
136–138]. The description of the diﬀerent techniques for
ultrasound-guided catheter insertion (needle out-of-plane
with nerve in short-axis approach and needle in-plane
with nerve in short-axis or long-axis approaches) are well
described in a recent editorial [139].
The combination of nerve stimulation (insulated needle
or stimulating catheter) and ultrasound guidance for cath-
eter placement is controversially discussed in the literature,Anesthesiology Research and Practice 5
and often the diﬃculties are major compared to the single
use of either technique [101, 140–142].
In certain situations ultrasound might be, at least the-
oretically, superior to nerve stimulation for example when
sensory nerves are the target [143], after limb amputations
[144] if there is no phantom sensation to guide nerve
stimulation [145], when vascular puncture is an absolute
contraindication like in anticoagulated patients [146], or
when an electrically induced muscle response is impossible
[147]o rn o td e s i r e d[ 148]. However, ultrasound needle and
catheter tip visualization are often diﬃcult specially in deep
structures. In these cases, nerve stimulation might prove
beneﬁcial [149].
4.LocalAnesthetics,InfusionRates,and
DeliveryStrategies
4.1. Local Anesthetics & Adjuncts. The most commonly used
local anesthetics for cPNB are bupivacaine and ropivacaine,
and both seem to provide adequate analgesia without major
toxicity. However, ropivacaine is known to be more “motor
sparing” [55] and less cardiotoxic compared to bupivacaine
[150]. However, cases of toxicity involving both bupivacaine
and ropivacaine are almost exclusively related to a single
large injection of local anesthetic. At the concentrations
of 0.15% for bupivacaine and 0.2% for ropivacaine, they
seem to provide similar analgesia with little diﬀerence
in hand strength preservation [151, 152]. Recently, for
interscalene cPNB after open rotator cuﬀ repair ropivacaine
0.3%wascomparedto0.2%showingadecreaseinmorphine
consumption, a better sleep quality, and no impairment in
hand strength [55].
To prolong the eﬀect of local anesthetics, the addition
of diﬀerent drugs to local anesthetics has been suggested for
sPNB and cPNB like opioids [165, 166], epinephrine [167],
and clonidine [168], but their safety or clinical beneﬁts like
reduction of local anesthetic use for cPNB remain unclear
[169, 170].
4.2. Infusion Rates and Delivery Strategies. Preliminary evi-
dence does not suggest a rigid local anesthetic delivery
system for all cPNB. According to the literature, total local
anesthetic dose and not its concentration or its delivery
rate mainly inﬂuences clinical eﬀects, although this issue
is currently disputed in the literature [55, 162, 171–176].
At the moment, insuﬃcient information is available to
base recommendations on the optimal basal rate, bolus
volume, and lockout period for the diﬀerent variables that
may aﬀect these values (catheter location, catheter type,
surgical procedure, etc.). As a rule, we can state that basal
infusion of local anesthetic reduces breakthrough pain and
improves sleep quality [33, 173, 177]. The addition of
patient-controlled bolus doses further improves analgesia
allowing a reduction of the basal rate and further allowing
a reduction of opioids and their related side eﬀects [33].
However, the comparison of basal-bolus and basal-only
techniques related to pain scores and patient satisfaction is
controversially disputed in the literature [33, 34, 177].
Reducing the basal rate might reduce the risk of toxicity
and the reduction of motor and sensory block could prevent
the risk for patient falls [178].
Until prospectively collected data are available, possible
dose recommendations based on randomized controlled
studies and clinical experience are given in Table 3. Although
the maximum recommended hourly total dose of all local
anesthetics during perineural infusion is still unknown
[179], a wide safety margin has been reported in numerous
clinical trials [180, 181].
For the outpatient setting, many types of pumps are
on the market: reusable and disposable, nonelectronic and
electronic, basal-only and basal-bolus capable [22, 182].
Nonelectronic disposable infusion pumps are divided in
elastomeric, positive-pressure (spring-powered and gas-
pressure-powered), and negative-pressure (vacuum) pumps
[183].Themodelchosenhastobeadaptedtotheneedsofthe
patient and meet with the costs. In clinical trials comparing
electronic-programmable pumps with elastomeric pumps,
elastomeric pumps have been shown to oﬀer similar postop-
erativeanalgesiaforfewertechnicalproblemsandlowercosts
[184]. In clinical practice, they were easy to use and accurate
in function [185].
5. Why cPNB Insteadof sPNB?
5.1. Pain Therapy. Diﬀerent case reports suggest beneﬁcial
eﬀects of cPNB for diﬀerent indications [12, 186, 187],
but published RCTs include only postoperative patients and
addressmainlypainrelief,whichisconsideredtobethemain
indication for cPNB [21].
Although single-injection nerve blocks (sPNB) also pro-
videexcellentanalgesia,cPNBincreasestheﬂexibilityofboth
duration and density of local anesthetic eﬀect depending
on the chosen dose. SPNB oﬀers a good pain therapy for
up to 24 hours but for this duration a dense motor block
and important sensory loss must be taken into account.
In situations like trauma surgery, where compartment
syndrome might be masked by these dense and long-lasting
blocks, these properties are not wished by the surgeon.
However, there is not enough evidence to support the thesis
that patient-controlled analgesia with opioids or regional
analgesia delay the diagnosis of compartment syndrome
provided patients are adequately monitored [188, 189].
Continuous peripheral nerve blocks oﬀer the possibility to
adapt to the diﬀerent needs by lowering the volume or
the concentration of the local anesthetic [153, 190]. This
ﬂexibility reduces the need for a large initial bolus reducing
the risk of systemic toxicity. Moreover, the reduction of
dense motor and sensory blocks reduces the risk of falls
and positioning injury [178, 191, 192]. An increase of local
anesthetic concentration can also improve patient outcome.
Borgeat et al. increased the ropivacaine concentration for
interscalene blocks from 0.2 to 0.3% after rotator cuﬀ repair
anddescribed asigniﬁcantreductionofmorphine consump-
tion and a better sleep quality for the ﬁrst postoperative
night without increasing the intensity of motor block or side
eﬀects [55].6 Anesthesiology Research and Practice
Table 3: Recommended doses of diﬀerent local anesthetics for diﬀerent catheter locations and their administration regimen according
to clinical practice of the authors (CP), own publications or based on selected randomized controlled trials. Ropi: ropivacaine; Bupi:
bupivacaine; B: basal rate (ml/h); Bo: bolus (ml); L: lockout (min). The used literature for Interscalene [55, 58, 153–157], infraclavicular
[33, 59], axillary, [7]f e m o r a l[ 158–160], Fascia iliaca [161], subgluteal sciatic [162], and popliteal sciatic [51, 52, 78, 163, 164].
Catheter location Local anesthetic Infusion rate
Interscalene
(i) Ropi 0.2% (i) CP: B: 4–6; Bo: 4–6; L: 20–30
(ii) Ropi 0.3% (ii) CP: B: 3–5; Bo: 3-4; L: 20–30
(iii) Bupi 0.125% (sufentanil 0.1µg/ml and clonidine 1µg / m l ) ( i i )C P :B :5 ;B o :2 . 5 ;L :3 0
Infraclavicular (i) Ropi 0.2% (i) CP: B: 4–6; Bo:4–6; L: 20–60
Axillary (i) Bupi 0.25% (i) B: 10 / B: 0; Bo: 10; L: 60
Femoral
(i) Hip surgery
(ii) Knee surgery
(i) Hip (i) Hip
( a )R o p i0 . 2 % ( a )B :6 ;B o :4 ;L :3 0
(b) Bupi 0.125% (+sufentanil 0.1µg/ml and clonidine
1µg/ml)
(b) B: 10 / B: 0; Bo: 10; L: 60 / B: 0;
Bo 5; L: 30
(ii) Knee (ii) Knee
(a) Ropi 0.2% (a) CP: B: 3–6; Bo: 2–4; L: 20–30min
(b) Bupi 0.125% (clonidine 1µg/ml) (b) B: 5; Bo: 2.5; L: 30
Fascia iliaca (knee surgery) (i) Ropi 0.2% (i) B: 5; Bo: 5; L: 60 / B: 0; Bo: 10; L: 60
Subgluteal sciatic (i) Ropi 0.2% (i) B: 5; Bo: 5; L: 60
Popliteal sciatic (i) Ropi 0.2% (i) CP: B:4–6; Bo: 4–6; L: 20
(ii) Levobupi 0.125% (ii) B: 5; Bo: 3; L:15
5.2. Upper Extremity. Most of cPNB beneﬁts are mainly
dependent on successfully improving pain control, reducing
opioid consumption and its related side eﬀects and increas-
ing patient satisfaction [21]. Like for shoulder and elbow
surgery, potent analgesia is achieved and maintained with
cPNB due to their complete innervation by nerves aﬀected
by the perineural infusion [55, 58, 59].
For shoulder and upper arm surgery, the interscalene
nerve block (ISNB) has become a standard procedure in
specialized centers [193]. This technique has been evaluated
in diﬀerent RCTs using either neurostimulator or ultrasound
and as has been shown to be superior to settings using
subcutaneous/oral opioids or even opioid-based patient
controlled analgesia (PCA) [27, 34, 58, 138, 153–155, 194–
200]. The superiority of continuous interscalene block
(cISNB) towards single-shot interscalene block (sISNB) was
demonstrated for moderate painful and extremely painful
surgery in diﬀerent studies [153–155, 196, 200, 201].
The beneﬁts for elbow surgery using continuous infra-
clavicular perineural block is well validated [202], but good
analgesia needs a high dose of local anesthetic leading to
insensateextremities[175].However,forsurgicalprocedures
distal to the elbow, brachial plexus infusions seem to provide
less impressive analgesia [202]. Moreover, beneﬁts of axillary
[203] and supraclavicular [204, 205] continuous infusions
demonstrated by RCTs are still lacking.
5.3. Lower Extremity. Femoral or posterior lumbar plexus
infusions are well validated for hip [158, 187, 206, 207]
and knee surgery in RCTs [208–210]b u tm i g h tr e s u l ti n
dangerous quadriceps femoris and hip adductor weakness if
high doses of local anesthetic are administered to optimize
analgesia [178]. Moreover, contrary to the brachial plexus, in
thelowerextremityasingleperineuralinfusionwillnotcover
all surgical sites as these are innervated by multiple nerves.
Therefore, a single perineural infusion might not provide
optimal analgesia without the concurrent use of additional
analgesics [171, 211]. A valid method to achieve optimal
analgesia is the supplementation of a continuous perineural
infusion with a separate single-injection peripheral nerve
block as is often done for knee arthroplasty (continuous
femoral nerve block complemented by a sciatic block) [212].
Inserting a second catheter for continuous perineural infu-
sion has been suggested [26, 206, 213], but limited available
data are conﬂicting and not useful to establish a clear clinical
practice [26, 214]. Moreover, the recent review by Paul et
al. [215] has brought new light into the clinical standard
for pain management after total knee arthroplasty. Only two
RCTs [211, 216] compared single-shot femoral nerve block
to continuous infusion of local anesthetic according to his
inclusion criteria. The additional use of single-shot sciatic
nerve block was also investigated. According to the chosen
methodology he suggested that at the moment, there is not
enough evidence to support the use of neither a single-
shot sciatic nerve block nor a continuous perineural femoral
nerve block in addition to a single-injection femoral nerve
block [217]. Despite the emotional reactions to this review
[218] fearing that the use of cPNB will be questioned by
surgeons according to the missing evidence, further studies
shouldaddressthisquestiontoestablishthecorrectapproach
for this surgery [212].
Also if lumbar epidural provides generally equivalent
analgesia to femoral perineural infusion for both, hip and
knee arthroplasty cPNB oﬀers a more favorable side eﬀect
proﬁle avoiding the risk of epidural hematoma during
anticoagulant administration [25, 207]. Therefore, cPNB hasAnesthesiology Research and Practice 7
to be considered the method of choice if regional anesthesia
is indicated for the lower extremity.
For foot and ankle surgery, the use of cPNB has clearly
demonstrated its superiority to other analgesia regimens.
It has been shown to decrease hospital costs and length
of stay [219]. Several studies have shown that regional
anesthesia for foot surgery is safe and does lead to reduced
perioperative opioid requirements [56, 57, 220]. Patients
have reported improved sleep, reduced pain scores, and
fasterrecoverytimes[162,190,221–223].Patientsatisfaction
scores improved after regional anesthesia compared with
general anesthetic with following systemic analgesia [224–
226]. Recently, Blumenthal et al. described, that an addi-
tional femoral nerve catheter with ropivacaine 0.2% to a
continuous popliteal catheter with ropivacaine 0.2% both
for 48 hours for major ankle surgery reduces pain during
motion compared to popliteal catheter alone. This eﬀect was
still present after 6 months suggesting that short-duration
regional anesthesia has a late impact on residual pain after
major ankle surgery [26].
6. Functional Outcome
6.1. Short-Term Use of cPNB. The eﬀects of the short-term
use of cPNB on functional outcome after orthopedic surgery
are still controversially discussed. Ilfeld et al. reported in a
retrospective study that in the 3 days after a total shoulder
arthroplasty, a continuous interscalene block using ropiva-
caine 0.2% was associated with increased range of shoulder
motion due to the complete analgesia provided [227]. These
results were supplemented by a following prospective study
analyzing the eﬀects of ambulatory continuous interscalene
nerve block after shoulder arthroplasty [27]. Authors con-
cluded that an ambulatory continuous interscalene nerve
block considerably decreased the time until readiness for
discharge(deﬁnedasachievementofapreviouslyestablished
range of motion and good pain control) after shoulder
arthroplasty. This result was achieved primarily by providing
potent analgesia permitting greater passive shoulder move-
ment and by the avoidance of intravenous opioids. However,
recently Hofmann-Kiefer et al. compared a continuous
interscaleneinfusionoflocalanestheticwithanopioid-based
PCA regimen. They reported that continuous interscalene
block improved analgesia without improving postoperative
function during early rehabilitation of the shoulder joint.
[198]. For knee surgery, De Ruyter et al. reported that
a continuous femoral nerve block provided satisfactory
analgesia, improved rehabilitation, and reduced hospital
lengthofstaycomparedwithopiates[228].Contrary,Raimer
et al. described better analgesia with continuous psoas and
sciatic blocks or epidural catheters compared to opioid PCA
regarding pain levels, analgesic requirements, and patient
satisfaction. However, there was no diﬀerence in functional
outcome between the 3 groups [229].
6.2. Beneﬁts after Catheter Removal. Despite the over-
whelming evidence highlighting cPNB beneﬁts during local
anesthetic infusion, there exist few data demonstrating
beneﬁts after catheter removal. These data include improved
analgesia a few days after removal [61, 186, 216]a n da f t e r
6 months [26], faster resumption of unassisted standing
[186], and improved passive knee ﬂexion leading to earlier
discharge from rehabilitation centers [25, 230]. The often
cited increase in health-related quality of life has been shown
only in 1 study [231] but could not be reproduced in many
other more recent studies [232–236].
These results are in accordance with the review by
Liu and Wu analyzing the eﬀect of analgesic technique
on postoperative patient-reported outcomes [20]. Authors
found that regional anesthesia oﬀered better postoperative
analgesia control with reduction of opioid-related side
eﬀects, but there were insuﬃcient and inconsistent data to
support subsequent improvement in quality of life, quality
of recovery, satisfaction, and length of hospital stay.
Therefore, more studies focusing on the medium- or
long-term improvements in health-related quality-of-life
measures are needed [234, 237].
6.3. Impact on Postoperative Cognitive Dysfunction. Post-
operative cognitive dysfunction (POCD) is an important
issue in an aging society. Postoperative cognitive dysfunction
is a poorly deﬁned condition as numerous studies use
diﬀerent deﬁnitions and neuropsychological tests to detect
potentially altered short- or longer-term memory, motor
control or information processing following anesthesia.
There is evidence that altered intraoperative physiology
may inﬂuence POCD and longer-term outcomes. A meta-
analysis of 21 studies on POCD and postoperative delirium
(POD) found no eﬀect of anaesthesia type on the odds
ratio of developing POD (0.88, 95% CI 0.51–1.51) [238].
However, it has been suggested that avoidance of general
anesthesia and of central acting analgesics in the elderly leads
to reduced postoperative long-term cognitive dysfunction
[163]. The most recent study suggesting that anesthesia
regimen has no impact on cognitive dysfunction had severe
protocol inaccuracies, as the regional anesthesia group
(spinal anesthesia) was premedicated with a benzodiazepine,
anotherbenzodiazepinewasaddedpriortospinalanesthesia,
abispectralindex<60wasachievedwithpropofolorwithgas
during surgery, and pain therapy was performed with oral
oxycodone and subsequent morphine PCA [164]. Further
well-designed studies are needed to assess the impact of
continuousregionalanesthesiaforsurgeryandpostoperative
pain treatment on the incidence of POCD.
7. Ambulatory and Home Therapy
Apartfromtheclassicalpostoperativesetting,cPNBhasbeen
successfully introduced in the ambulatory surgery setting for
both adults [134, 191] and pediatric patients [239].
Continuous peripheral nerve blocks oﬀer the oppor-
tunity to deliver eﬀective pain therapy at home and are
considered to be a valid alternative to opioid-based analgesia
and its related side eﬀects [240]. However, a proper patient
selectionisessentialforsafecPNBathome,asnotallpatients8 Anesthesiology Research and Practice
are willing to accept the extra responsibility of the catheter
a n dp u m ps y s t e m[ 191, 240].
Additionally, patients with known hepatic or renal
insuﬃciency are excluded from ambulatory cPNB to avoid
possible local anesthetic toxicity [241]. Obese patients and
those with heart or lung disease who cannot compensate
for mild hypercarbia and/or hypoxia are excluded from
interscalene and cervical paravertebral infusions, which are
known to aﬀect the phrenic nerve and ipsilateral diaphragm
function [155].
8. Economical Outcome
The advantages of sPNB over general anesthesia related
to cost-eﬀectiveness in the operation theatre have been
recently described by Gonano et al. for shoulder arthroscopy
[242]. Authors could show that ultrasound-guided inter-
scalene blocks lead to an improvement of anesthesia-
related workﬂow and to a reduction of postanesthesia care
unit (PACU) time compared to general anesthesia. The
positive eﬀects of regional anesthesia on the anesthesia-
related costs are well known: reduction of postoperative
nausea and vomiting, reduced length of stay, successful
same day discharge, reduction of unplanned admission or
readmission, reduction of multiple-day hospitalizations to
single days, earlier discharge, reduction or even elimination
of PACU length of stay leading to reduced postoperative
nursing interventions, faster discharge times, and reduction
of operating room time without increase in turnover time
[211, 243–245]. Fredrickson and Stewart compared recently
continuous interscalene nerve block for rotator cuﬀ repair to
combined single injection interscalene block with additional
postoperative intermittent intra-articular local anaesthetic
inﬁltration and to intermittent intra-articular only local
anaesthetic inﬁltration. Authors concluded that continuous
interscalene nerve block following rotator cuﬀ repair in
a multiprovider setting was associated with reduced total
opioid/tramadol and antiemetic consumption, without a
signiﬁcant increase in the monetary costs [246].
Unfortunately, there are no studies comparing sPNB and
cPNB regarding cost-eﬀectiveness. However, the duration of
hospitalization [247] or even the need for hospitalization
[248] can be reduced by the use of cPNB reducing inpatient
treatment costs.
9. Beneﬁts of cPNBs
The impact of cPNBs on analgesia has been described
in many RCTs and has been elucidated above [21]. The
related dramatic decrease in required supplemental opioids,
opioid-related side eﬀects, and sleep disturbances, while
simultaneously increasing patient satisfaction are further
beneﬁts [190]. Moreover, a decreased time to adequate
ambulation with additional optimization of daily activities
after ambulatory cPNB compared with intravenous opioids
has been described [34]. For continuous regional anesthesia
following shoulder and knee arthroplasty, an accelerated
improvement of passive joint range of motion potentially
leading to shorter hospitalization has been described [25, 27,
216, 230].
Ambulatory shoulder arthroplasty and 23-hour-stay
knee and hip arthroplasty using ambulatory continuous
interscalene, femoral, and psoas compartment nerve blocks,
respectively have been reported [247, 249, 250].
However, although postknee arthroplasty inﬂammation
is reduced after a continuous femoral nerve block [186].
the cPNB could not produce major improvements in long-
term outcomes such as decreased chronic pain and improved
health-related quality of life [20, 235, 251]. Studies focusing
on long-term outcomes are lacking to evaluate the eﬀects of
cPNB after 6 and 12 months on costs, functional outcome
and socioeconomic aspects.
10.AdverseEffects
Two prospective investigations involving more than 2.100
patients suggest that the incidence of cPNB-related com-
plications is very low and comparable to sPNB techniques
[58, 252]. However, diﬀerent catheter insertion techniques,
diﬀerent anatomic locations, variations in equipment and
diﬀerent infusion regimens make comparisons diﬃcult. In
fact, several prospective studies report an incidence of
secondary block (during infusion) failure of 1% [253], 20%
[197], and 50% [254]. Therefore, all reported complications
in this chapter cannot be translated to the diﬀerent clinical
practices.
10.1. Minor Complications. These complications are fre-
quentlyseeninclinicalpracticeandincludecatheterobstruc-
tion, catheter dislodgement, ﬂuid leakage, disconnection
from the pump system, infusion pump malfunction, and
skin irritation or allergic reactions to the sterile catheter
dressing [202, 252, 253, 255, 256].
10.2. cPNB-Speciﬁc Complications. These seldom but possi-
ble complications include inaccurate catheter tip placement
resulting too far from the target nerve and therefore lacking
successful analgesia, [74] or in an undesirable position like
intravascular [257], intrapleural [258], intraneural [259],
epidural [260] or even intrathecal. [261–263]. However,
whether catheter migration is possible after correct place-
ment remains unclear [264, 265].
10.3. Infections. Most studies reporting infection in relation
with cPNB derive from hospitalized patients even if data for
large outpatient series are increasing. Although the reported
rates of inﬂammation (3%-4%) [86, 252, 253] and catheter
bacterial colonization (6%–57%) are apparently high [266,
267], the incidence of catheter infection for inpatients ranges
from 0% to 3.2% [252,266,268], and foroutpatient rates are
below 1% [191, 269].
Risk factors for infection in the setting of cPNB include
lack of or inappropriate antibiotic prophylaxis, and axil-
lary or femoral catheter location [269]. However, other
studies have reported the interscalene location as the most
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are admission to an intensive care unit, male sex [252],
and increased infusion duration [252]. Though, some case
reports demonstrate that prolonged catheter use for more
than 30 days is possible without increased rate of infection
[15]. There is limited evidence proving that subcutaneous
catheter tunneling [270] may decrease the risk of bacterial
colonization and infection.
Although life-threatening catheter-related infections and
sepsis have been reported in the literature [271, 272], no
published case of permanent injury due to cPNB-related
infection is reported in the literature [269].
Sterility precautions while ﬁlling the infusion pumps are
of utmost importance. In a recent case report of a severe,
deep cellulitis, evolving to mediastinitis was attributed to
contaminated infusate from a pump which was manipulated
innonsterileconditions[272].Therefore,anesthetistsshould
act upon the recommendations of the American Society of
Regional Anesthesia and Pain Medicine (ASRA) using sterile
precautions such as antiseptic hand washing, sterile gloves,
surgical masks and hats, and using alcohol-based chlorhexi-
dine antiseptic solutions to avoid such complications [40].
10.4. Neurologic Complications. Although neurologic injury
associated with cPNB is usually transient ranging from
0.3% to 2.0% [33], it remains the most feared concern
performing regional anesthesia. Injury may occur during
catheter placement or even in the postoperative period. For
regional anesthesia in general the incidence of transient
adverse neurologic symptoms associated with cPNB is 0% to
1.4% for interscalene [253, 273], 0.4% to 0.5% for femoral
[252, 274], and 0% to 1.0% for sciatic catheters [266, 274].
Neuburger et al. described a 0.2% incidence of neurologic
deﬁcits lasting more than 6 weeks in nearly 3.500 catheters
from multiple anatomic locations [253]. However, it remains
unknown whether the deﬁcits resolved spontaneously after
the 6-week study period. Other prospective investigations
report that the overwhelming majority of neurologic symp-
toms still present at 4 to 6 weeks resolve spontaneously
within 3 months of surgery [252, 273].
There are also cases of long-term or permanent nerve
injury in patients after perineural infusion [275]. In ﬁve
large, prospective series with patient followups at least three
months after, 3 cases of unresolved adverse neurologic events
were found [58, 252, 266, 273, 274]. The combination of
these results including 4.148 patients suggests that the risk
of neurologic injury lasting longer than 9 months associated
with cPNB is 0.07%. The role of the continuous infusion for
the evolution of these complications remains unclear.
Only few reports of nerve injury in patients sent home
with cPNB are described in the current literature. However,
pressure injury due to insensate extremity has been impli-
cated as a likely cause [10]. Therefore, particular precautions
must be taken when casts or splints are placed on patients
with insensate extremities.
A further important neurologic concern associated with
in- and out-patient cPNB is the risk of falls. Williams
et al. reported recently 1.7% of outpatients treated with
continuous femoral nerve block fell due to insensate lower
extremity despite adequate instructions how to behave at
home [192]. Ilfeld et al. pooled data from 3 previously pub-
lished, randomized, triple-masked, and placebo-controlled
studies of cPNB involving the femoral nerve after knee
and hip arthroplasty and demonstrated a causal relationship
between cPNB and the risk of falling after these surgical
interventions [178].
This complication elucidates the potential beneﬁt in
providing low-concentration blocks that preserve more
motor function and proprioception. Moreover, the desire to
oﬀer complete analgesia should be balanced against the risk
of falling. Therefore, the recently published study dealing
with multimodal analgesic approaches including regional
anesthesia can oﬀer a solution to achieve excellent analgesia
while preserving motor function [276].
10.5. Local Anesthetic Toxicity. Most investigators report
basal hourly infusion rates of 5 to 10mL/h using dilute
solutions of either ropivacaine or bupivacaine [33, 34].
Despite these low rates of infusion, local anesthetic toxicity is
reported as a possible complication of cPNB [277]. Systemic
local anesthetic toxicity is a serious but rare complication
using cPNB [278, 279]. Although, continuous infusion is
unlikely to result in sudden onset of toxicity, patients treated
with a pump with bolus capability are at risk if intravascular
migration should occur. A further rare complication is
myonecrosis after repeated large boluses of bupivacaine
[280]. Also if there is in vitro and animal evidence for local
anesthetic-caused neurotoxicity [281, 282], there seems to be
little evidence that the risk of nerve injury from prolonged
local anesthetic exposure might be increased in patients
suﬀering diabetes or preexisting neuropathies [283, 284].
11. FutureDirections
Local anesthetics act on the voltage-gated sodium channels
[285]. The Nav1.7is the main channel for pain transmission
in the peripheral nerves [286, 287]. Selective blocking of
this channel for the postoperative period could be of special
interest for ambulant cPNB avoiding the risk of falls. A high
selective Nav1.7 local anesthetic would increase the ambulant
use of cPNB with probably a remarkable impact in health
costs.
L i p o s o m e sa sr e s e r v o i r sf o rd r u g sa r eb i o c o m p a t i b l e
due to their biodegradability and low toxicity [288]. They
can reduce the exposure of sensitive tissues like nerves to
potentially toxic drugs like high concentrations of local
anesthetics. Their administration is independent of technical
skills required for catheter placement as a variety of routes
are possible (topical, intramuscular, nasal, subcutaneous,
oral, pulmonary, and intravenous) [289]. Even though
not yet approved for peripheral nerve blocks, liposomal
formulations of various local anesthetics oﬀer an increase in
clinical eﬃcacy compared with the plain drugs [290]. Actual
limitations of encapsulated local anesthetics are myotoxicity,
neurotoxicity, tachyphylaxis, viscosity, and motor block
[291]. Clinical studies describe a prolonged analgesia after
inﬁltration and epidural application [292, 293]. Once the10 Anesthesiology Research and Practice
potential adverse eﬀects like a prolonged motor block and
toxicity are eliminated, these promising clinical results might
be transferred to peripheral regional anesthesia.
12. Conclusions
The Literature provides a plethora of information involving
cPNB, but some aspects of perineural infusion remain
controversial: the optimal catheter insertion modality, the
optimal technique for each indication, the infusates oﬀering
the best safety, standardized local anesthetic delivery regi-
mens, and optimization of continuous ambulatory infusion
to reduce possible risks (as falling). The optimal analgesic
technique for many surgical procedures has to be further
elucidated, and cPNB must be compared with possible new
analgesic techniques/regimens [231].
The new application areas for local anesthetic such as
anti-inﬂammatory eﬀects/anticancer eﬀects [294, 295]h a v e
to be further investigated, and cPNB must be included in
clinical trials addressing these topics.
The socioeconomical aspect of anesthesia remains an
important issue, and the role of cPNB for in hospital and
at home use and their eﬀects in the healing process and the
readmission of the patients at work after surgery must be
clariﬁed.
Prospective research addressing the above-mentioned
issues can maximize the potential beneﬁts and minimize the
potential risks of cPNBs.
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